The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Bay City Capital Management V Llc since 2013.
The trader's CIK number is 1461543.
At the time of the last reporting, Bay City Capital Management V Llc was the 10% Owner of Interleukin Genetics Inc. (stock ticker symbol ILI).
Also see all insider trading activities at Interleukin Genetics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | EPZM | 555,555 | $4,999,995 | 0 | $0 | 0 | $0 |
2014 | EPZM | 0 | $0 | 566,666 | $19,613,483 | 0 | $0 |
2013 | EPZM | 166,666 | $2,499,990 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | ILIU | 30,181,086 | $2,987,927 | 0 | $0 | 0 | $0 |
2014 | ILIU | 26,491,952 | $2,649,195 | 0 | $0 | 0 | $0 |
2. Interleukin Genetics Inc (ILIU)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-01-12 | EPZM | Buy | 555,555 | 9.00 | 4,999,995 |
2014-08-26 | EPZM | Sale | 200,000 | 35.14 | 7,027,800 |
2014-08-25 | EPZM | Sale | 200,000 | 35.77 | 7,153,600 |
2014-08-22 | EPZM | Sale | 128,000 | 32.46 | 4,154,752 |
2014-08-21 | EPZM | Sale | 38,666 | 33.03 | 1,277,331 |
2013-06-05 | EPZM | Buy | 166,666 | 15.00 | 2,499,990 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-07-29 | ILIU | Buy | 30,181,086 | .10 | 2,987,927 |
2014-12-23 | ILIU | Buy | 26,491,952 | .10 | 2,649,195 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bay City Capital Management V Llc (10% Owner of Interleukin Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.